These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23377585)

  • 1. Conjunctivochalasis as a contributing factor for the development of ocular surface disease in medically treated glaucoma patients.
    Kocabeyoglu S; Mocan MC; Irkec M; Orhan M; Karakaya J
    J Glaucoma; 2014; 23(5):333-6. PubMed ID: 23377585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.
    Saade CE; Lari HB; Berezina TL; Fechtner RD; Khouri AS
    Can J Ophthalmol; 2015 Apr; 50(2):132-6. PubMed ID: 25863853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approach for conjunctivochalasis using an argon green laser.
    Yang HS; Choi S
    Cornea; 2013 May; 32(5):574-8. PubMed ID: 22929155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.
    Uzunosmanoglu E; Mocan MC; Kocabeyoglu S; Karakaya J; Irkec M
    Cornea; 2016 Aug; 35(8):1112-6. PubMed ID: 27055218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion.
    Erdogan-Poyraz C; Mocan MC; Irkec M; Orhan M
    Cornea; 2007 Apr; 26(3):290-3. PubMed ID: 17413955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.
    Kocabeyoglu S; Mocan MC; Irkec M
    Acta Ophthalmol; 2014 Nov; 92(7):e592-3. PubMed ID: 24774884
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis.
    Erdogan-Poyraz C; Mocan MC; Bozkurt B; Gariboglu S; Irkec M; Orhan M
    Cornea; 2009 Feb; 28(2):189-93. PubMed ID: 19158563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication.
    Ghosh S; O'Hare F; Lamoureux E; Vajpayee RB; Crowston JG
    Clin Exp Ophthalmol; 2012; 40(7):675-81. PubMed ID: 22394358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of conjunctivochalasis on dry eye symptoms and signs.
    Chhadva P; Alexander A; McClellan AL; McManus KT; Seiden B; Galor A
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):2867-71. PubMed ID: 26024073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surface and tear parameters in patients with chronic hepatitis C at initial stages of hepatic fibrosis.
    Karaman Erdur S; Kulac Karadeniz D; Kocabora MS; Ozsutcu M; Gulkilik IG; Demirci G; Eliacik M
    Eye Contact Lens; 2015 Mar; 41(2):117-20. PubMed ID: 25503914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
    Saini M; Dhiman R; Dada T; Tandon R; Vanathi M
    Eye (Lond); 2015 Jun; 29(6):808-14. PubMed ID: 25857609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasis.
    Fodor E; Barabino S; Montaldo E; Mingari MC; Rolando M
    Curr Eye Res; 2010 Aug; 35(8):665-9. PubMed ID: 20673042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
    Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
    Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
    Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
    Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis.
    Gumus K; Yurci A; Mirza E; Arda H; Oner A; Topaktas D; Karakucuk S
    Cornea; 2009 Oct; 28(9):997-1002. PubMed ID: 19724213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ocular surface disease in patients with glaucoma.
    Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
    Ophthalmology; 2013 Nov; 120(11):2241-8. PubMed ID: 23714318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.